Muhlenberg College is a private liberal arts college located in Allentown, Pennsylvania, United States. Founded in 1848, Muhlenberg is affiliated with the Evangelical Lutheran Church in America and is named for Henry Melchior Muhlenberg, the German patriarch of the Lutheran Church in America. Wikipedia.
News Article | April 27, 2017
NEW YORK--(BUSINESS WIRE)--Deutsche Bank continues to strengthen its investment in Global Markets Americas, and today announced the hiring of David Silber as Head of Americas Equity Derivatives, and Eoin Milligan, a Director in Equities. David Silber joins in June as Managing Director and Head of Americas Equity Derivatives, where he will be responsible for both Sales and Trading across Equity Derivatives. Silber has nearly 20 years of banking experience, and was most recently Managing Director and Head of North American Execution Sales at Citi where he was responsible for the equity derivatives business across the region. Prior to Citi, Silber spent six years at Jefferies & Company where he was most recently Head of Equity Derivatives. Silber received his B.A. from Muhlenberg College in Pennsylvania. He will be based in New York and report to Brad Kurtzman, Head of Americas Equities, and John O’Brien, Head of Americas Equity Distribution. Deutsche Bank also hired Eoin Milligan as Director. Milligan has more than 15 years of experience building technological solutions for the financial industry, and was most recently Director at Bank of America where he was responsible for building strategic risk and exposure management applications. Prior to Bank of America, Milligan was at J.P. Morgan in a similar role. Milligan received his B.S. from The Cooper Union for The Advancement of Science and Arts, his M.S. in Electrical Engineering from Columbia University and his MBA from New York University. He is based in New York and reports to Miguel Barrio, Managing Director, Global Markets, Equities. “ These hires represent the continued investment in our US equities business. We are looking forward to welcoming David and Eoin to our team,” said Brad Kurtzman, Head of Americas Equities. Deutsche Bank announced earlier this month that it hired Lori Arndt as Global Head of Client Strategy in Equities, Christopher McCarthy as a Director in Global Credit Trading, and Ronnie Shah as a Director in Research. Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific. This release contains forward-looking statements. Forward-looking statements are statements that are not historical facts; they include statements about our beliefs and expectations and the assumptions underlying them. These statements are based on plans, estimates and projections as they are currently available to the management of Deutsche Bank. Forward-looking statements therefore speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events. By their very nature, forward-looking statements involve risks and uncertainties. A number of important factors could therefore cause actual results to differ materially from those contained in any forward-looking statement. Such factors include the conditions in the financial markets in Germany, in Europe, in the United States and elsewhere from which we derive a substantial portion of our revenues and in which we hold a substantial portion of our assets, the development of asset prices and market volatility, potential defaults of borrowers or trading counterparties, the implementation of our strategic initiatives, the reliability of our risk management policies, procedures and methods, and other risks referenced in our filings with the U.S. Securities and Exchange Commission. Such factors are described in detail in our SEC Form 20-F of 11 March 2016 under the heading “Risk Factors”. Copies of this document are readily available upon request or can be downloaded from www.db.com/ir.
News Article | July 18, 2017
DC Tripodi, Mortgage Loan Officer, Affinity Federal Credit Union, has joined The Expert Network©, an invitation-only service for distinguished professionals. Mr. Tripodi has been chosen as a Distinguished Mortgage Professional™ based on peer reviews and ratings, dozens of recognitions, and accomplishments achieved throughout his career. Mr. Tripodi outshines others in his field due to his numerous awards and recognitions, outstanding customer service, and career longevity. After studying mathematics and business administration at Muhlenberg College, he worked as a branch manager for the United National Bank focusing on bank operations, commercial lending, and home equity programs. He also had the opportunity to work as the manager of Business Development for a behavioral assessment company, which he credits with helping him to understand the multitude of personalities he deals with in his current career. When he transitioned towards mortgage lending in 2001, he discovered he had an aptitude for the work, welcoming the challenge of understanding and learning guidelines for many different loan types. With 15 years of experience, Mr. Tripodi brings a wealth of knowledge to his industry and, in particular, his area of expertise, residential loans, and lending services. When asked what inspired him to pursue a career in mortgages, Mr. Tripodi said, "I felt like I understood people, and when you understand people, you have a knack for sales. And I considered my experience in banking and some experience in business management and behavioral assessment, and I felt like mortgage lending would allow me to combine several talents I already had." As a thought-leader in his field, it is important for Mr. Tripodi to keep his clients and potential clients educated on all things mortgage related. As such, he hosts numerous first-time buyer seminars designed to answer all questions about the home buying process. Most recently he hosted one on the dos and don'ts of home buying and one on jumbo loans. With such influence, he is sure to keep his eye on prevailing trends within the mortgage industry and in particular to the shortage of homes the market is now seeing. He noted: "There is currently a lot of pent up demand, but not much supply, so there are many buyers making offers on the same property. It seems that a lot of families are focused on locations close to train stations for easier commuting, so those neighborhoods are especially having difficulty when it comes to people looking to buy easily. My experience helps me to understand different personalities in the sales world and understand different approaches to helping people make their home buying decisions. I have worked for very large financial institutions as well as smaller lending companies and these past employers helped me grow an understanding of sales and its many layers. It has given me a solid understanding of the real estate world and in gaining relationships with financial professionals." Mr. Tripodi is a member of the Hunterdon-Somerset Association of REALTORS® and the Passaic, NJ County Board of REALTORS®. He also is a dedicated volunteer with the Sunshine Kids Foundation. For more information, visit Mr. Tripodi's profile on the Expert Network© here: https://expertnetwork.co/members/dc-tripodi/2c141895252364dd The Expert Network© has written this news release with approval and/or contributions from DC Tripodi. The Expert Network© is an invitation-only reputation management service that is dedicated to helping professionals stand out, network, and gain a competitive edge. The Expert Network© selects a limited number of professionals based on their individual recognitions and history of personal excellence.
News Article | July 17, 2017
VALENCIA, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that Steven Binder has joined the company as its Chief Financial Officer with full responsibilities for leading MannKind’s finance, accounting, and investor relations organization on a global basis, effective immediately. Mr. Binder will report directly to Michael Castagna, Pharm.D., Chief Executive Officer and will join the company’s executive leadership team. Mr. Binder joins MannKind with over 25 years of experience in the healthcare industry. He most recently spent four years at Stryker Corporation, a leading global medical technology company, where he served as Vice President and Chief Financial Officer for Stryker’s International Group, based in Singapore. Prior to Stryker, Mr. Binder served in a series of senior leadership roles at Bristol-Myers Squibb Company, an innovative global biopharmaceutical company. His last four positions at BMS were Vice President, Finance roles over different geographic operating units: United States (2012-2013), Europe (2008-2011), AsiaPacific (2005-2007), and Japan (2003-2005). Prior to his international experience, Mr. Binder served in three senior leadership roles for Oncology Therapeutics Network, a U.S. based independent subsidiary of BMS: Vice President, Strategic Development (2001-2003), Vice President, Customer Operations (2000-2001), and Chief Financial Officer (1997-2000). Before OTN, Mr. Binder progressed through three finance and accounting roles for BMS Worldwide Medicines Group after joining the company in 1992. Before BMS, he worked for Deloitte & Touche in a series of auditing roles with increasing responsibility over an eight year period beginning in 1984. Mr. Binder received a B.S. degree in Accounting and Business Administration from Muhlenberg College and is a Certified Public Accountant. “We are very excited to have Steve join MannKind and our executive leadership team. His deep experience in finance and his commercial acumen acquired through a variety of senior leadership roles in multi-national healthcare companies will be a clear competitive advantage for us,” said Dr. Castagna, Chief Executive Officer of MannKind. “Steve joins MannKind at an exciting period as we develop into a world class biopharmaceutical company.” Dr. Castagna continued, “I would like to thank Rose Alinaya for her leadership as Acting Chief Financial Officer prior to Steve’s hiring. Rose will now transition to leading investor relations for MannKind, a very important capability for us moving forward, reporting directly to Steve.” Mr. Binder commented, “MannKind is well-positioned for future growth and I could not be more excited about being a part of this team. I believe Afrezza is an innovative product with great potential to improve the quality of life for diabetic patients.” About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. Forward-Looking Statements This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding the commercial potential of Afrezza. Words such as “believes”, “anticipates”, “plans”, “expects”, “intend”, “will”, “goal", “potential” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MannKind’s current expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risks detailed in MannKind’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2016 and subsequent periodic reports on Form 10-Q and current reports on Form 8-K. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
News Article | July 25, 2017
NEW YORK--(BUSINESS WIRE)--Deutsche Bank today announced the hiring of Glen Santangelo to lead US Equity Research coverage of the Healthcare Technology & Distribution sector. Today’s announcement rounds out a year-long investment in Healthcare at Deutsche Bank. “ Over the past year, we have invested strategically and significantly in our Healthcare research platform,” said Steve Pollard, Deutsche Bank Global Head of Equity Research. “ Our platform now offers clients comprehensive Healthcare research coverage designed to match their sector needs with an ability to generate unique market insight.” “ Healthcare is a clear area of investment across CIB in the Americas,” added Mark Fedorcik, co-head of Americas CIB. “ We are committed to making hires that reinforce our client offering and position us well in this active sector.” Glen Santangelo will join the bank in July as a Managing Director. Santangelo has more than 20 years of experience in healthcare research and joins from Credit Suisse where he was US Co-Director of Research. Prior to that, he led the Credit Suisse Healthcare team and was named to the Institutional Investor All-American Research Team for seven consecutive years beginning in 2009. He received his BS in Accounting from Villanova University and his MBA from New York University. Santangelo will be based in New York and report to Steve Pollard. Over the past twelve months, the bank has also hired Chris Rigg to cover Healthcare Services, Dan Leonard to cover Life Science & Diagnostics Tools, and Andrew Peters and Navin Jacob to cover Biotechnology. The analysts all report to Steve Pollard. Navin Jacob and Andrew Peters joined Deutsche Bank in March 2017 and May 2016, respectively, as Directors to cover the US Biotechnology sector. Prior to joining Deutsche Bank, Jacob was a senior analyst covering Global Pharmaceuticals at Healthcor Management and earlier covered US Biotech & Pharmaceuticals at Citadel Asset Management. Jacob received his BA in Biochemistry at Cornell University. He is based in New York. Prior to joining, Peters was a Director and led the Small & Mid Cap Biotechnology franchise at UBS. Peters received his Master of Bioscience and MBA from Claremont McKenna College. He is based in San Francisco. Chris Rigg joined Deutsche Bank in January 2017 as a Director and equity research analyst covering the Healthcare Facilities & Managed Care sector. Prior to joining Deutsche Bank, Rigg was a senior Managed Care & Healthcare Facilities analyst at Susquehanna Financial Group and was named one of Institutional Investor’s ‘Rising Stars of Wall Street.’ Rigg received his BA in Business Administration and History from Muhlenberg College and his MBA from New York University. He is based in New York. Dan Leonard joined Deutsche Bank in September 2016 as a Director and equity research analyst covering the Life Science & Diagnostic Tools sector. Prior to joining Deutsche Bank, Leonard was a senior Life Science and Diagnostic Tools analyst at Leerink Partners. Leonard received his MBA with Honors from The Booth School of Business at the University of Chicago and his BA in Economics with Distinction from the University of Michigan. He is based in New York. The investment in US Equity Research has been complemented with new hires in Investment Banking. Deutsche Bank recently announced the hiring of Phillip Pucciarelli as a Managing Director and Co-Head of Americas Healthcare Investment Banking, alongside Ross Hammerman who joined the bank in July 2016. It also hired Robert Verdier as a Managing Director in Healthcare Services, Nick Richitt as a Managing Director focused on Healthcare IT and Outsourcing, William White as a Managing Director and Head of US Life Sciences, Glenn Rewick as a Managing Director in M&A focused on Healthcare, and Matt Jackson as a Director focused on Healthcare. Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific. This release contains forward-looking statements. Forward-looking statements are statements that are not historical facts; they include statements about our beliefs and expectations and the assumptions underlying them. These statements are based on plans, estimates and projections as they are currently available to the management of Deutsche Bank. Forward-looking statements therefore speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events. By their very nature, forward-looking statements involve risks and uncertainties. A number of important factors could therefore cause actual results to differ materially from those contained in any forward-looking statement. Such factors include the conditions in the financial markets in Germany, in Europe, in the United States and elsewhere from which we derive a substantial portion of our revenues and in which we hold a substantial portion of our assets, the development of asset prices and market volatility, potential defaults of borrowers or trading counterparties, the implementation of our strategic initiatives, the reliability of our risk management policies, procedures and methods, and other risks referenced in our filings with the U.S. Securities and Exchange Commission. Such factors are described in detail in our SEC Form 20-F of 11 March 2016 under the heading “Risk Factors”. Copies of this document are readily available upon request or can be downloaded from www.db.com/ir.
News Article | June 8, 2017
As head of ETFs, Rosenberg will be responsible for creating American Century's new line of ETFs, an investment vehicle that has surged in popularity with investors in recent years. In 2016, net share issuance of U.S. ETFs reached a record $284 billion, with total assets exceeding $2.5 trillion, according to the Investment Company Institute1. Rosenberg will leverage the expertise of the firm's experienced investment teams to develop a suite of ETFs – including active ETFs – for investors. Unlike passive ETFs, which are designed to track an index, active ETFs are actively managed on a daily basis by a portfolio manager or team of managers making investment decisions in pursuit of a specific investment objective. Rosenberg also will be responsible for building relationships with market makers, authorized participants and exchanges. "Our clients know and already appreciate the active management capabilities we will harness as we develop new ETF strategies," said Peruvemba Satish, American Century senior vice president, portfolio manager and director of global analytics. "With the active ETF segment of the market still in the early stages of development, we're confident American Century can be a very relevant player by providing the solutions our clients need now and in the future." Prior to joining FlexShares in 2012, Rosenberg was director and head of capital markets and analytics with Russell Investments, where he helped launch the majority of the firm's current ETFs. Earlier in his career, he served in a variety of leadership positions at Vanguard, including ETF product manager. Rosenberg graduated from Muhlenberg College with a bachelor's degree in business administration and a master's degree in business administration from Pennsylvania State University. American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting research that can improve human health and save lives. Founded in 1958, American Century Investments' 1,300 employees serve investment professionals, institutions, corporations and individual investors from offices in New York; London; Hong Kong; Mountain View, Calif.; and Kansas City, Mo. Jonathan S. Thomas is president and chief executive officer, and Victor Zhang and David MacEwen serve as co-chief investment officers. Delivering investment results to clients enables American Century Investments to distribute over 40 percent of its dividends to the Stowers Institute for Medical Research, a 500-person, non-profit basic biomedical research organization. The Institute owns more than 40 percent of American Century Investments and has received dividend payments of nearly $1.3 billion since 2000. For more information about American Century Investments, visit www.americancentury.com. Shares of exchange-traded funds (ETFs) represent interests in portfolios of securities, much like mutual funds. Unlike mutual funds, however, ETFs trade throughout the day on an exchange like an individual stock, with prices established by the market. An ETF generally tracks an underlying benchmark or index, such as the S&P Index. *$165.3 billion in assets under management as of April 30, 2017 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/edward-rosenberg-joins-american-century-investments-to-oversee-the-firms-exchange-traded-funds-initiative-300470962.html
News Article | May 10, 2017
LearnHowToBecome.org, a leading resource provider for higher education and career information, has determined its ranking of the best colleges in Pennsylvania for 2017. 50 four-year schools were included on the list, with University of Pennsylvania, Lehigh University, Carnegie Mellon University, Duquesne University and University of Scranton ranked as the top five. 25 two-year schools were also ranked, with Thaddeus Stevens College of Technology, Harrisburg Area Community College—Harrisburg, University of Pittsburgh—Titusville, Bucks County Community College and Manor College taking the top five spots on the list. A list of all winning schools is included below. “These Pennsylvania colleges and universities offer not only great degree programs but also excellent resources for preparing students for post-college careers,” said Wes Ricketts, senior vice president of LearnHowToBecome.org. “They have demonstrated superior overall value to students by providing an overall positive, high-quality educational experience.” To be included on the “Best Colleges in Pennsylvania” list, institutions must be regionally accredited, not-for-profit schools. Each college is also ranked on metrics like the variety of degree programs offered, the number of employment and academic resources offered, financial aid availability, graduation rates and annual alumni earnings 10 years after entering college. Complete details on each college, their individual scores and the data and methodology used to determine the LearnHowToBecome.org “Best Colleges in Pennsylvania” list, visit: Best Four-Year Colleges in Pennsylvania for 2017 include: Allegheny College Arcadia University Bryn Mawr College Bucknell University Carnegie Mellon University Cedar Crest College Chatham University DeSales University Dickinson College Drexel University Duquesne University Eastern University Elizabethtown College Franklin and Marshall College Gannon University Gettysburg College Gwynedd Mercy University Haverford College Holy Family University Immaculata University Juniata College King's College La Salle University Lafayette College Lebanon Valley College Lehigh University Marywood University Mercyhurst University Messiah College Misericordia University Moravian College Muhlenberg College Pennsylvania State University-Main Campus Rosemont College Saint Francis University Saint Joseph's University Saint Vincent College Susquehanna University Swarthmore College Temple University University of Pennsylvania University of Pittsburgh-Pittsburgh Campus University of Scranton University of the Sciences Ursinus College Villanova University Washington & Jefferson College Westminster College Widener University-Main Campus York College Pennsylvania Best Two-Year Colleges in Pennsylvania for 2017 include: Bucks County Community College Butler County Community College Commonwealth Technical Institute Community College of Allegheny County Community College of Beaver County Community College of Philadelphia Delaware County Community College Harcum College Harrisburg Area Community College - Harrisburg Johnson College Lackawanna College Lehigh Carbon Community College Luzerne County Community College Manor College Montgomery County Community College Northampton County Area Community College Pennsylvania Highlands Community College Pennsylvania Institute of Technology Pittsburgh Institute of Aeronautics Reading Area Community College Rosedale Technical Institute Thaddeus Stevens College of Technology University of Pittsburgh - Titusville Valley Forge Military College Westmoreland County Community College ### About Us: LearnHowtoBecome.org was founded in 2013 to provide data and expert driven information about employment opportunities and the education needed to land the perfect career. Our materials cover a wide range of professions, industries and degree programs, and are designed for people who want to choose, change or advance their careers. We also provide helpful resources and guides that address social issues, financial aid and other special interest in higher education. Information from LearnHowtoBecome.org has proudly been featured by more than 700 educational institutions.
Agency: NSF | Branch: Standard Grant | Program: | Phase: S-STEM:SCHLR SCI TECH ENG&MATH | Award Amount: 607.79K | Year: 2015
Muhlenberg College has received an NSF Scholarships for Science, Technology, Engineering, and Mathematics (S-STEM) award for a project entitled The Scholars in Math and Science (SIMS) program. SIMS will target academically talented and economically disadvantaged students who enter college seeking a major within the biological sciences. Two cohorts of 8 students each will be recruited: the first cohort will receive scholarships of $9,500/year for 4 years, and the second will receive scholarships of $9,500/year for 3 years. The proposal is building upon successful program elements of a previous STEM grant that included enhanced recruitment and academic support. Through this program, Muhlenberg College will promote a robust and diverse STEM workforce.
Program elements new to this project are being designed to develop academic and science skills, create a learning community that lasts from freshman to senior year, and develop student leadership through activities on campus and in public outreach. The project will improve student support services including forming learning communities, providing special classes and sections to get students past hurdle classes, instituting peer-led learning, and providing long-term mentors. SIMS will increase the leadership roles of scholars, improving their science process skills, encouraging participation in research, and improving recruitment and financial support for low income and otherwise underrepresented groups. SIMS assessment and evaluation will be comprehensive and ongoing and include both quantitative and qualitative instruments and measures from the literature. The project external evaluator is using both formative and summative evaluations to assess student mathematics readiness, skills development, ability to understand and communicate key principles in biology, progress to degree, and graduation rates. Particular emphasis will be placed on the surveys to assess and continually improve the elements of the program that are focused on student success. The data will inform our understanding of effective practices that support the persistence to graduation of students underrepresented in STEM disciplines.
Agency: NSF | Branch: Continuing grant | Program: | Phase: | Award Amount: 162.00K | Year: 2012
A thriving nuclear physics program for undergraduates at Muhlenberg College has been established. Sourced by activities with the PHENIX Collaboration, students and the primary investigator engage in summer research at Brookhaven National Laboratory (BNL). There, research using the Relativistic Heavy Ion Collider (RHIC) proceeds along two lines. The first line of inquiry is the study of nuclear matter at very high temperature and density, such as existed a few millionths of a second after the Big Bang. Under these conditions, a hot brew of quarks and gluons is created. RHIC recreates these conditions via the collision of nuclei at very high energies. The Muhlenberg group will help to characterize some of the properties of the plasma. The other line of inquiry is the quest to understand the source of the protons intrinsic angular momentum (or spin). As the only stable hadron, the proton is a system of fundamental importance. Protons and neutrons (collectively referred to as nucleons) constitute most of the mass of ordinary matter in the universe. PHENIX has implemented a new hardware upgrade, a Muon Trigger, to probe the contribution of antiquarks to the overall spin of the proton. The group will carry out performance studies of the Resistive Plate Chambers (RPCs) that are core components of the upgrade. Such studies are crucial to maintain the RPCs in good operating condition and to parameterize time dependencies in the RPC performance as input to the offline analysis. The information gleaned using this upgrade will supply answers to an important piece of the so-called spin puzzle. This collaborative activity at a national laboratory exposes students to research experiences they could not otherwise obtain at a small college. It provides students with new skills and a better understanding of the scientific enterprise, and it can help with informed career choices, whether in physics or in other areas.
Agency: NSF | Branch: Continuing grant | Program: | Phase: WORKFORCE IN THE MATHEMAT SCI | Award Amount: 107.97K | Year: 2016
This award provides support for REU Site: Research Challenges of Identifying Integer Sequences Using the OEIS, at Muhlenberg College. Projects make an effective use the On-line Encyclopedia of Integer Sequences (OEIS) as a resource tool, and provide glimpses into future. The research impact of the OEIS across disciplines continues to grow. Applications of the to the life sciences, physical sciences, and earth sciences abound. The OEIS has also impacted research in scientific and engineering fields beyond the mathematical sciences. There are currently more than 3,000 papers and books in many areas of mathematics, computer science, and many other branches of science that reference and/or acknowledge the OEIS. The large number of citations and links to OEIS attests to its impact on advancing many areas of active research and its appeal to a broad multidisciplinary community.
The intellectual focus of this research concentrates on the important role sequences play in mathematics, as well as their contributions to other fields. The program will contribute to the OEIS knowledge base through projects that are influenced by recent developments and tackle challenges of mathematical and scientific discovery inspired by integer sequences. These challenges include experimentation by developing computational algorithms and meta-algorithms through the use of computers. The methodologies applied to these challenges have come to be loosely defined as rigorous experimental mathematics and have proven effective in developing conjectures in areas that include number theory, algorithmic and enumerative combinatorics, combinatorial number theory, and many other mathematical fields. Our program aims to prepare students to become the next generation of mathematical scientists efficient in researching sequences and their applications through the OEIS database, the most successful of whom will have the capacity to look to the OEIS for inspiration. We will nurture this capacity by highlighting the contributions to the mathematical sciences of the On-Line Encyclopedia of Integer Sequences. A particular emphasis of our program will be to discuss the important role the OEIS has played in developing conjectures in areas that include number theory, algorithmic and enumerative combinatorics, combinatorial number theory, and many other mathematical and scientific fields, as well as the tools necessary for identifying such conjectures.
Agency: NSF | Branch: Continuing grant | Program: | Phase: Nuclear & Hadron Quantum Chrom | Award Amount: 110.00K | Year: 2015
It is now a well-established fact that nucleons, protons and neutrons, are made up of more elementary particles called quarks. The main physics program supported by this grant is to measure the energy of particles produced at small scattering angles from collisions of atomic nuclei at high energies, carried out at the Brookhaven National Lab using the PHENIX particle detector. These measurements will help to understand the new state of matter, a plasma of quarks, that is formed from such collisions. In particular, the results of this measurement are expected to probe the initial conditions of quarks and other strongly-interacting particles in the nucleus before the collision. In recent years, we have learned that the initial conditions of the quarks before the collision result in hot-spots within the quark-gluon plasma, and how these hot-spots spread their energy within the plasma provides information on this new state of matter. It is worth noting that this research program is carried out at an undergraduate institution, Muhlenberg College, and is a highlight of the Physics Department. Most of the physics majors have participated in it by the time of their graduation. Furthermore, almost all of the participants have chosen to continue in STEM fields after graduation.
Theorists have suggested that measurements of transverse energy are a barometer of a state of saturated plasma. Both studies of existing data from a relativistic heavy ion collisions (RHIC) experiment, called the beam energy scan, by the PHENIX Collaboration and work on transverse energy in the forward and backward kinematic regions are testing gluon-saturation models in ultra-relativistic heavy ion collisions. To date, transverse energy in the forward and backward kinematic regions has not been reported. Associated with regions of higher net baryon chemical potential on the phase diagram of nuclear matter, these measurements, along with existing transverse energy measurements at central rapidity for a variety of colliding systems and beam energies, provide new insight into the strongly interacting quark gluon plasma.